1. Market Research
  2. > Pathology
21 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • $ 900
  • June 2020
  • 82 pages

B-cell lymphomas can be categorized into aggressive NHL, such as diffuse large B-Cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and burkitt' s lymphoma (BL), and indolent NHL, such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma

  • Autoimmune Disease
  • Lymphoma
  • Therapy
  • World
  • AbbVie Inc.

Global Seed Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • $ 950
  • April 2020
  • 98 pages

lymphoma, solid tumors with NTRK gene fusions Nexavar, Nubeqa, Xofigo, Stivarga, Aliqopa, Vitrakvi Ophthalmology Visual impairment due to agerelated macular degeneration (AMD), diabetic macular edema (DME) or retinal vein occlusion (RVO) Eylea Hematology Hemophilia A Kogenate/ Kovaltry

  • Agricultural Products
  • Lymphoma
  • World
  • BASF SE
  • Bayer AG

Global Biologics Market: Size, Trends & Forecast (2019-2023 Edition)

  • $ 1200
  • December 2019
  • 97 pages

Enbrel ##. ## Rheumatoid arthritis Amgen, Pfizer Herceptin ##. ## Breast and gastric cancer Roche (Genentech) Avastin ##. ## Various cancers Roche (Genentech) Rituxin ##. ## Lymphoma, Rheumatoid arthritis Roche (Genentech), Biogen Eylea ##. ## Macular degeneration/ edema, retinopathy Bayer, Regeneron

  • Biopharmaceutical
  • Lymphoma
  • Medical Biotechnology
  • Pharmaceutical
  • World

Global Breast Implants Market with Focus on Breast Augmentation & Breast Reconstruction: Size, Trends and Forecasts (2019-2023)

  • $ 1200
  • August 2019
  • 116 pages

Also, smooth breast implants have a lower risk of suffering from breast implant-associated anaplastic large-cell lymphoma than textured breast implants.

  • Healthcare
  • Lymphoma
  • Medical Device
  • Prosthesis
  • World

Global Disinfectant Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • $ 900
  • May 2020
  • 92 pages

Food and Drug Administration (FDA) approval of IMBRUVICA (ibrutinib) in combination with rituximab for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) which are new to therapy.

  • Bleach
  • Household Cleaner
  • Infection Control
  • Lymphoma
  • World

Global Immuno-Oncology Market with Focus on Assays: Size, Trends and Forecasts (2019-2023)

  • $ 900
  • September 2019
  • 77 pages

On July ##, 2019, the US Food and Drug Administration (FDA) approved RUXIENCE, a biosimilar to Rituxan to treat the adult patients with lymphoma, leukemia and polyangiitis.

  • Lymphoma
  • Oncology
  • Therapy
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Global Small Molecule CMO Market: Size, Trends & Forecasts (2019-2023)

  • $ 800
  • March 2019
  • 66 pages

Takeda Pharmaceutical Company Limited announced in November 2018 that the European Commission (EC) granted marketing authorization for ALUNBRIG (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung canc

  • Lymphoma
  • Pharmaceutical
  • World
  • Catalent Pharma Solutions, Inc.
  • Lonza Group Ltd

Global Biologics Market: Size, Trends & Forecast (2018-2022)

  • $ 900
  • February 2018
  • 91 pages

Global Biologics Market: Size, Trends & Forecasts (2018-2022) February 2018 ##.

  • Biotech Services
  • Lymphoma
  • Medical Biotechnology
  • World
  • AbbVie Inc.

Global In-Vitro Diagnostic (IVD) Market: Size, Trends & Forecasts (2017-2021)

  • $ 800
  • November 2017
  • 79 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and west nile virus diseases.

  • Diagnostics
  • In Vitro Diagnostics
  • Lymphoma
  • World
  • Abbott Laboratories, Inc.

Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)

  • $ 800
  • November 2016
  • 58 pages

Lymphoma Phase III Recruiting participants PF-## (Humira) Follicular Lymphoma Phase III Ongoing PF-## (Remicade) Rheumatoid Arthritis Phase III Ongoing PF-## (Avastin) Non-Small Cell Lung Cancer Phase III HSP-## (Neulasta) Neutropenia in patients undergoing cance

  • Biosimilar
  • Lymphoma
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.

Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)

  • $ 800
  • October 2016
  • 37 pages

Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020) OCTOBER 2016 TABLE OF CONTENT ##.

  • Cancer
  • Cancer Diagnostics
  • Lung Cancer
  • Lymphoma
  • World

Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020)

  • $ 900
  • October 2016
  • 72 pages

The Development of MDV##: Pidilizumab that is in phase II clinical trials for the treatment of relapsed or refractory diffuse large B-cell lymphoma.

  • Lymphoma
  • Targeted Therapy
  • Therapy
  • World
  • AbbVie Inc.

US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)

  • $ 850
  • September 2016
  • 50 pages

Upper-extremity lymphedema most often occurs after breast cancer; lower-extremity lymphedema most often occurs with uterine cancer, prostate cancer, lymphoma, or melanoma.

  • Endocrine Disease
  • Lymphoma
  • Pathology
  • United States
  • Tactile Systems Technology, Inc.

Global Proton Therapy Market: Trends and Opportunities (2015 Edition)

  • $ 800
  • December 2015
  • 59 pages

Global Proton Therapy Market: Trends and Opportunities (2015 Edition) December 2015 ##. ##. ##.

  • Cancer
  • World
  • Market Size
  • Hitachi, Ltd.
  • Mitsubishi Corporation

China Cancer Drug Market: Size, Trends & Forecasts (2018-2022)

  • $ 800
  • June 2018
  • 70 pages

lymphomas including Waldenstrom' s macroglobulinemia (WM), chronic lymphocytic leukemia (CLL/ SLL), R/ R mantle cell lymphoma (MCL), follicular lymphoma (FL) etc.

  • Cancer
  • Lymphoma
  • China
  • World
  • Novartis AG

The US Lymphedema Market: Size, Trends & Forecasts (2019-2023 Edition)

  • $ 850
  • October 2019
  • 59 pages

Upper-extremity lymphedema most often occurs after breast cancer; lower-extremity lymphedema most often occurs with uterine cancer, prostate cancer, lymphoma, or melanoma.

  • Endocrine Disease
  • Lymphoma
  • Pathology
  • United States
  • Tactile Systems Technology, Inc.

Global Pulmonary Arterial Hypertension (PAH) Market: Trends & Opportunities (2015-2019)

  • $ 800
  • July 2015
  • 70 pages

Scope of the Report The report titled “Global PAH Market: Trends and Opportunities (2015-2019)”, analyzes the potential opportunities and significant trends in the global Pulmonary Arterial Hypertension ...

  • Lymphoma
  • Respiratory Treatment
  • Therapy
  • World
  • Actelion Ltd

Global Myasthenia Gravis Market: Size, Trends & Forecasts (2017-2021)

  • $ 800
  • August 2017
  • 61 pages

It was initially approved for the treatment of B-cell lymphomas, but more recently has been approved for use in rheumatoid arthritis.

  • Lymphoma
  • Neurological Disorder
  • Therapy
  • United States
  • Pfizer Inc.

Global Life Science and Diagnostic Tools Market: Size, Trends & Forecasts (2017-2021)

  • $ 800
  • November 2017
  • 64 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and west nile virus diseases.

  • Laboratory
  • Lymphoma
  • World
  • Demand
  • Danaher Corporation

Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020)

  • $ 850
  • September 2016
  • 68 pages

This drug is used to treat lymphoma, leukemia, sarcoma, etc.

  • Chemotherapy
  • Lymphoma
  • Therapy
  • World
  • Novartis AG
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on